Hidaya Mansouri
Research Subjects
Hidaya Mansouri has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Hamza Abdou Azali
National Research Institute for Agriculture, Fisheries and Environment (INRAPE), Ex CEFADER, M’dé, Ngazidja, Moroni P.O. Box 1406, Comoros
2 shared publications - Ahmed Irchad
National Research Institute for Agriculture, Fisheries and Environment (INRAPE), Ex CEFADER, M’dé, Ngazidja, Moroni P.O. Box 1406, Comoros
1 shared publication - Ahmed Irchad
National Research Institute for Agriculture, Fisheries and Environment (INRAPE), Ex CEFADER, M’dé, Ngazidja, Moroni P.O. Box 1406, Comoros
1 shared publication Amos R. Mwakigonja
Department of Pathology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania
1 shared publication- Charaf Ed-Dine Kassimi
Agro-Food Technology and Quality Laboratory, Regional Center of Agricultural Research of Meknes, National Institute of Agricultural Research, Rabat 10090, Morocco
1 shared publication - Clarence Rubaka
The Nelson Mandela African Institution of Science and Technology (NM-AIST), Arusha P.O. Box 447, Tanzania
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (5) , 303
Nutraceutical Profiles and FTIR Fingerprints of Comorian Coffea canephora and Coffea liberica var. dewevrei
Background/Objectives: Coffea canephora (robusta) and Coffea liberica var. dewevrei (excelsa) cultivated in the Comoros islands represent understudied coffee varieties grown in a unique volcanic terroir. Despite their agricultural significance and potential bioactive value, no comprehensive biochemical or nutritional characterization of these Comorian coffees had previously been conducted. This study therefore aimed to provide the first integrated biochemical and nutritional characterization of both varieties and to evaluate the influence of the islands’ specific edaphoclimatic conditions on their chemical composition. Methods: An integrated analytical approach was employed, combining UV-Vis spectrophotometry, HPLC, ionomics, and FTIR-ATR spectroscopy to quantify polyphenols, flavonoids, caffeine, soluble sugars, antioxidant activity, mineral profiles, and macromolecular composition of green coffee beans from both species. Results: Robusta exhibited significantly higher levels of total polyphenols (121.79 ± 2.73 mg GAE/g), total flavonoids (29.43 ± 2.20 mg QE/g), caffeine (1.52% w/w), total soluble sugars (60.47 ± 3.37 mg GE/g), and antioxidant activity (64.97 ± 6.25 mM Trolox eq/g). Conversely, excelsa demonstrated a distinct mineral profile, with significantly higher concentrations of magnesium, calcium, sodium, zinc, and copper. FTIR spectroscopy confirmed distinct vibrational fingerprints between the two species, particularly in lipid and carbohydrate signatures. Conclusions: These findings position Comorian robusta as a potent source of antioxidants and stimulants, while excelsa offers a nutritionally balanced profile with nutraceutical potential, providing a scientific basis for valorizing both varieties as high-value niche products and contributing to the preservation of coffee agro-biodiversity.
- 29 April 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (5) , 303
Open AccessNutraceutical Profiles and FTIR Fingerprints of Comorian Coffea canephora and Coffea liberica var. dewevrei
Background/Objectives: Coffea canephora (robusta) and Coffea liberica var. dewevrei (excelsa) cultivated in the Comoros islands represent understudied coffee varieties grown in a unique volcanic terroir. Despite their agricultural significance and potential bioactive value, no comprehensive biochemical or nutritional characterization of these Comorian coffees had previously been conducted. This study therefore aimed to provide the first integrated biochemical and nutritional characterization of both varieties and to evaluate the influence of the islands’ specific edaphoclimatic conditions on their chemical composition. Methods: An integrated analytical approach was employed, combining UV-Vis spectrophotometry, HPLC, ionomics, and FTIR-ATR spectroscopy to quantify polyphenols, flavonoids, caffeine, soluble sugars, antioxidant activity, mineral profiles, and macromolecular composition of green coffee beans from both species. Results: Robusta exhibited significantly higher levels of total polyphenols (121.79 ± 2.73 mg GAE/g), total flavonoids (29.43 ± 2.20 mg QE/g), caffeine (1.52% w/w), total soluble sugars (60.47 ± 3.37 mg GE/g), and antioxidant activity (64.97 ± 6.25 mM Trolox eq/g). Conversely, excelsa demonstrated a distinct mineral profile, with significantly higher concentrations of magnesium, calcium, sodium, zinc, and copper. FTIR spectroscopy confirmed distinct vibrational fingerprints between the two species, particularly in lipid and carbohydrate signatures. Conclusions: These findings position Comorian robusta as a potent source of antioxidants and stimulants, while excelsa offers a nutritionally balanced profile with nutraceutical potential, providing a scientific basis for valorizing both varieties as high-value niche products and contributing to the preservation of coffee agro-biodiversity.
- Top Cited PapersOpen Access
- 2 February 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (2) , 170
Botanical Adjuvants in Oncology: A Review on Natural Compounds in Synergy with Conventional Therapies as Next-Generation Enhancers of Breast Cancer Treatment
Breast cancer remains a major global health challenge despite advances in chemotherapy, endocrine therapy, targeted therapy, and radiotherapy, which are frequently constrained by therapeutic resistance, cumulative toxicity, and high costs. Accumulating preclinical and translational evidence demonstrates that plant-derived natural compounds can synergistically enhance the efficacy of conventional treatments, improve tumor response, and potentially reduce adverse effects. This review critically synthesizes in vitro, in vivo, and emerging clinical studies from 2015 to 2025, focusing on key phytochemicals, including curcumin, epigallocatechin-3-gallate, resveratrol, kaempferol, genistein, and other bioactive molecules as stand alone agents and as mechanistically validated adjuvants to chemotherapy, hormonal therapy, and radiotherapy. These compounds exert complementary actions, including the inhibition of PI3K/Akt/mTOR and NF-κB signaling, induction of apoptosis and cell-cycle arrest, suppression of epithelial–mesenchymal transition, and modulation of drug resistance pathways. Preclinical studies consistently show that combination strategies enhance tumor inhibition and may permit cytotoxic dose reduction, mitigating systemic and cardiotoxic effects. Nanocarrier-based delivery systems further optimize solubility, bioavailability, and tumor targeting. Despite robust preclinical evidence, clinical translation is limited by variability in raw materials, lack of standardization, regulatory barriers, and scarce large-scale trials. This review emphasizes both the therapeutic promise and translational challenges of integrating natural compounds as synergistic adjuvants in evidence-based breast cancer therapy.
- 2 February 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (2) , 170
Top Cited PapersOpen AccessBotanical Adjuvants in Oncology: A Review on Natural Compounds in Synergy with Conventional Therapies as Next-Generation Enhancers of Breast Cancer Treatment
Breast cancer remains a major global health challenge despite advances in chemotherapy, endocrine therapy, targeted therapy, and radiotherapy, which are frequently constrained by therapeutic resistance, cumulative toxicity, and high costs. Accumulating preclinical and translational evidence demonstrates that plant-derived natural compounds can synergistically enhance the efficacy of conventional treatments, improve tumor response, and potentially reduce adverse effects. This review critically synthesizes in vitro, in vivo, and emerging clinical studies from 2015 to 2025, focusing on key phytochemicals, including curcumin, epigallocatechin-3-gallate, resveratrol, kaempferol, genistein, and other bioactive molecules as stand alone agents and as mechanistically validated adjuvants to chemotherapy, hormonal therapy, and radiotherapy. These compounds exert complementary actions, including the inhibition of PI3K/Akt/mTOR and NF-κB signaling, induction of apoptosis and cell-cycle arrest, suppression of epithelial–mesenchymal transition, and modulation of drug resistance pathways. Preclinical studies consistently show that combination strategies enhance tumor inhibition and may permit cytotoxic dose reduction, mitigating systemic and cardiotoxic effects. Nanocarrier-based delivery systems further optimize solubility, bioavailability, and tumor targeting. Despite robust preclinical evidence, clinical translation is limited by variability in raw materials, lack of standardization, regulatory barriers, and scarce large-scale trials. This review emphasizes both the therapeutic promise and translational challenges of integrating natural compounds as synergistic adjuvants in evidence-based breast cancer therapy.
- 1 July 2020
- Published by Farname, Inc. in Multidisciplinary Cancer Investigation
- Vol. 4 (3) , 5-14
A Review on the Status of Breast Cancer Care in Tanzania
Tanzania continues to enjoy stability and growth in different sectors similar to other countries; however, some challenges persist in the health sector, especially in the area of cancer care. The current study aimed at reviewing social economic status (SES), as well as factors contributing to the increased burden of breast ...
- 1 July 2020
- Published by Farname, Inc. in Multidisciplinary Cancer Investigation
- Vol. 4 (3) , 5-14
A Review on the Status of Breast Cancer Care in Tanzania
Tanzania continues to enjoy stability and growth in different sectors similar to other countries; however, some challenges persist in the health sector, especially in the area of cancer care. The current study aimed at reviewing social economic status (SES), as well as factors contributing to the increased burden of breast ...
- Open Access
- 9 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Ki-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania
This study associated Ki-67, p53, and BCL-2 markers with clinical histopathological (CH) features using currently available limited data on these markers in Tanzania. Retrospective chart review study was conducted among females with confirmed breast cancer (BC) at Muhimbili National Hospital in Tanzania between 2016 and 2017. Inclusion criteria were met by 76 patients with a mean age of 51.32 ± 14.28 years. Of these, 86.4% were stage III and IV, whereas 83.5% cases had grade 2 and grade 3. Upon immunostaining, 85.5% and 57.9% were Ki-67 and BCL-2 positive respectively. Log-linear analysis showed no statistically significant association among biomarkers expression and CH features. However, multinomial linear regression showed higher possibility for association between high expression of Ki-67, low expression of p53 and high expression of BCL-2 with age, grade, stage and tumor (T) stage. BCL-2 was positively correlated with Ki-67 expression contrary to p53, which was negatively correlated with BCL-2. Conclusively, there is evidence of correlation between the studied markers with CH features. However, studies with larger sample sizes will likely reveal significant associations that will validate the role of these markers as tools for evaluating treatment response in individualized therapeutic schemes in Tanzania.
- 9 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Open AccessKi-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania
This study associated Ki-67, p53, and BCL-2 markers with clinical histopathological (CH) features using currently available limited data on these markers in Tanzania. Retrospective chart review study was conducted among females with confirmed breast cancer (BC) at Muhimbili National Hospital in Tanzania between 2016 and 2017. Inclusion criteria were met by 76 patients with a mean age of 51.32 ± 14.28 years. Of these, 86.4% were stage III and IV, whereas 83.5% cases had grade 2 and grade 3. Upon immunostaining, 85.5% and 57.9% were Ki-67 and BCL-2 positive respectively. Log-linear analysis showed no statistically significant association among biomarkers expression and CH features. However, multinomial linear regression showed higher possibility for association between high expression of Ki-67, low expression of p53 and high expression of BCL-2 with age, grade, stage and tumor (T) stage. BCL-2 was positively correlated with Ki-67 expression contrary to p53, which was negatively correlated with BCL-2. Conclusively, there is evidence of correlation between the studied markers with CH features. However, studies with larger sample sizes will likely reveal significant associations that will validate the role of these markers as tools for evaluating treatment response in individualized therapeutic schemes in Tanzania.